首页> 外文期刊>The journal of clinical endocrinology and metabolism >Differential Regulation of Plasma Obestatin and Ghrelin by Meal Intake and the Cholinergic System in Lean, But Not Obese Individuals
【24h】

Differential Regulation of Plasma Obestatin and Ghrelin by Meal Intake and the Cholinergic System in Lean, But Not Obese Individuals

机译:膳食摄入量和胆碱能系统对瘦但未肥胖个体血浆雌激素和生长素释放肽的差异调节

获取原文
           

摘要

Context: Obestatin is cosecreted with and stemming from the same precursor as ghrelin and is apparently involved in energy metabolism. Relatively little is known about the regulation of obestatin release.Objective: The regulation of obestatin release and obestatin-to-ghrelin ratios by meal intake and the cholinergic system were studied in lean and obese subjects.Design, Participants, and Setting: We conducted a randomized, double-blind, placebo-controlled, crossover study with 4 study days in eight obese (body mass index >30 kg/m~(2)) and eight matched lean (body mass index <25 kg/m~(2)) healthy subjects (two males and six females per group) at a University Clinical Research Unit.Interventions: Atropine (1 mg iv) was administered alone and in combination with breakfast (550 kcal) intake, or placebo (isotonic saline) alone and in combination with breakfast.Main Outcome Measures: We measured plasma obestatin and obestatin/ghrelin ratios.Results: Both obestatin and ghrelin/obestatin ratios decreased significantly from baseline by either atropine or meal intake in lean individuals, with the two effects adding up on the combined atropine/breakfast day. In contrast, there were no statistically significant differences in obese subjects, who also showed significantly greater association between ghrelin and obestatin values than their lean counterparts.Conclusions: Obestatin and ghrelin release is differentially regulated by meal intake and the cholinergic system in lean individuals. This regulation is impaired in obesity.
机译:背景:肥胖抑制素与生长素释放肽同一个前体,与之起共分泌作用,显然参与能量代谢。关于肥胖抑制素释放的调控知之甚少。目的:研究瘦弱和肥胖受试者对膳食摄入和胆碱能系统对肥胖抑制素释放和肥胖抑制素与生长素释放肽之比的调节。设计,参与者和环境:随机,双盲,安慰剂对照,交叉研究,在8个肥胖(体重指数> 30 kg / m〜(2))和8个匹配的瘦肉(体重指数<25 kg / m〜(2))中进行4个研究日)大学临床研究部门的健康受试者(每组2名男性和6名女性)干预措施:阿托品(1 mg iv)单独服用,并与早餐(550 kcal)摄入或安慰剂(等渗盐水)一起服用主要结果指标:我们测量了血浆中的肥胖抑制素和肥胖抑制素/生长素释放肽的比率。结果:瘦素个体摄入的阿司匹林或膳食摄入的肥胖抑制素和生长激素释放肽/肥胖抑制素的比率均较基线水平显着降低,这两种影响加在一起阿托品/早餐日。相比之下,肥胖受试者没有统计学上的显着差异,他们的生长激素释放肽和肥胖抑制素值之间的相关性也显着高于瘦者。结论:肥胖饮食中肥胖抑制素和生长激素释放素的释放受进餐量和胆碱能系统的差异调节。肥胖会损害这种调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号